SAM
HAE icon

Smartleaf Asset Management’s Haemonetics HAE Stock Holding History

Smartleaf Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2K Hold
269
– – ﹤0.01% 2004
2026
Q1 		$14.8K Sell
269
-9
-3% -$586 ﹤0.01% 2125
2025
Q4 		$22.5K Buy
278
+140
+101% +$9.41K ﹤0.01% 1971
2025
Q3 		$6.64K Sell
138
-28
-17% -$1.73K ﹤0.01% 2275
2025
Q2 		$12.3K Sell
166
-92
-36% -$6.09K ﹤0.01% 1751
2025
Q1 		$16.3K Buy
258
+124
+93% +$8.43K ﹤0.01% 1705
2024
Q4 		$10.3K Buy
134
+14
+12% +$1.13K ﹤0.01% 1974
2024
Q3 		$9.58K Buy
120
+54
+82% +$4.36K ﹤0.01% 1779
2024
Q2 		$5.49K Buy
+66
New +$5.81K ﹤0.01% 1753

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's HAE Position: Q2 2026 in Review

Smartleaf Asset Management held its Haemonetics (HAE) position steady in Q2 2026 at 269 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

Smartleaf Asset Management first reported a position in HAE in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.5K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Smartleaf Asset Management held 269 shares of Haemonetics worth $20.2K as of Q2 2026.
  • Smartleaf Asset Management left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2004 holding.
  • Smartleaf Asset Management first reported a position in Haemonetics in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Haemonetics position peaked at $22.5K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.